SOD1 and amyotrophic lateral sclerosis: Furthermore, the ability of triterpenoids to activate the Nfr2/ARE pathway was investigated by Neymotin et al., who found that, compared to untreated mice, SOD1- G93A SOD1 mice treated with triterpenoids in the presymptomatic stage of ALS showed reduced weight loss, improved motor performance and prolonged survival.